共 30 条
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
被引:1537
作者:
De Strooper, B
[1
]
Annaert, W
Cupers, P
Saftig, P
Craessaerts, K
Mumm, JS
Schroeter, EH
Schrijvers, V
Wolfe, MS
Ray, WJ
Goate, A
Kopan, R
机构:
[1] Katholieke Univ Leuven VIB, Ctr Human Genet, Neuronal Cell Biol & Gene Transfer Lab, B-3000 Louvain, Belgium
[2] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, D-37073 Gottingen, Germany
[3] Washington Univ, Div Dermatol, St Louis, MO 63110 USA
[4] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[5] Univ Tennessee, Dept Pharmaceut Sci, Memphis, TN 38138 USA
[6] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
来源:
关键词:
D O I:
10.1038/19083
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Signalling through the receptor protein Notch, which is involved in crucial cell-fate decisions during development, requires ligand-induced cleavage of Notch. This cleavage occurs within the predicted transmembrane domain, releasing the Notch intracellular domain (MCD), and is reminiscent of gamma-secsretase-mediated cleavage of beta-amyloid precursor protein (APP), a critical event in the pathogenesis of Alzheimer's disease. a deficiency in presenilin-1 (PS1) inhibits processing of APP by gamma-secretase in mammalian cells, and genetic interactions between Notch and PS1 homologues in Caenorhabditis elegans indicate that the presenilins may modulate the Notch signalling pathway(1-4). Here we report that, in mammalian cells, PS1 deficiency also reduces the proteolytic release of NICD from a truncated Notch construct, thus identifying the specific biochemical step of the Notch signalling pathway that is affected by PS1. Moreover, several gamma-secretase inhibitors block this same step in Notch processing indicating that related protease activities are responsible for cleavage within the predicted transmembrane domains of Notch and APP. Thus the targeting of gamma-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signalling.
引用
收藏
页码:518 / 522
页数:5
相关论文